Xiaobo Hu

747 total citations
27 papers, 583 citations indexed

About

Xiaobo Hu is a scholar working on Molecular Biology, Surgery and Cell Biology. According to data from OpenAlex, Xiaobo Hu has authored 27 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Surgery and 8 papers in Cell Biology. Recurrent topics in Xiaobo Hu's work include Endoplasmic Reticulum Stress and Disease (8 papers), Pancreatic function and diabetes (7 papers) and Pancreatitis Pathology and Treatment (3 papers). Xiaobo Hu is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (8 papers), Pancreatic function and diabetes (7 papers) and Pancreatitis Pathology and Treatment (3 papers). Xiaobo Hu collaborates with scholars based in China and United Kingdom. Xiaobo Hu's co-authors include Zhaohui Cao, Duan‐Fang Liao, Bin Li, Yuyu Liu, Moshe Laudon, Zheng Ruan, Shanbai Xiong, Tingting Duan, Zhuowei Hu and Gebo Wen and has published in prestigious journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and Carbohydrate Polymers.

In The Last Decade

Xiaobo Hu

24 papers receiving 573 citations

Peers

Xiaobo Hu
Yuting Wu China
Mohamed Samir Ahmed Zaki Saudi Arabia
Zhen Shi China
Deepti Ramachandran United States
Rocco Caminiti Italy
Nan Lin China
Anil Ahsan China
Mirko Magnone Italy
Ching‐Long Lai Taiwan
Sara Santa-Cruz Calvo United States
Yuting Wu China
Xiaobo Hu
Citations per year, relative to Xiaobo Hu Xiaobo Hu (= 1×) peers Yuting Wu

Countries citing papers authored by Xiaobo Hu

Since Specialization
Citations

This map shows the geographic impact of Xiaobo Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo Hu more than expected).

Fields of papers citing papers by Xiaobo Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobo Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo Hu. The network helps show where Xiaobo Hu may publish in the future.

Co-authorship network of co-authors of Xiaobo Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobo Hu. A scholar is included among the top collaborators of Xiaobo Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobo Hu. Xiaobo Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhou, Qing, et al.. (2025). Polygonatum cyrtonema Polysaccharides Target Gut Microbiota to Suppress NOD2-Driven Inflammation and Modulate Bile Acid Metabolism in Colitis. Journal of Agricultural and Food Chemistry. 73(32). 20190–20204.
3.
Qiu, Ming, et al.. (2025). Puerarin prevents cadmium-induced endoplasmic reticulum stress via SIRT1-dependent PERK-CHOP pathway in HepG2 cells. Acta Biochimica et Biophysica Sinica. 57(8). 1304–1311. 1 indexed citations
4.
5.
Zeng, Min, et al.. (2024). Disulfiram: A novel repurposed drug for cancer therapy. Chinese Medical Journal. 137(12). 1389–1398. 25 indexed citations
6.
Hu, Xiaobo, et al.. (2023). ROS‐mediated PERK‐CHOP pathway plays an important role in cadmium‐induced HepG2 cells apoptosis. Environmental Toxicology. 38(9). 2271–2280. 5 indexed citations
7.
Zeng, Min, et al.. (2022). PFKL, a novel regulatory node for NOX2-dependent oxidative burst and NETosis. Journal of Zhejiang University SCIENCE B. 23(7). 607–612. 3 indexed citations
8.
Cao, Zhaohui, et al.. (2022). Curcumin ameliorates H<sub>2</sub>O<sub>2</sub>-induced injury through SIRT1-PERK-CHOP pathway in pancreatic beta cells. Acta Biochimica et Biophysica Sinica. 54(3). 370–377. 12 indexed citations
9.
Hu, Xiaobo, et al.. (2022). Pyroptosis in diabetes and diabetic nephropathy. Clinica Chimica Acta. 531. 188–196. 49 indexed citations
10.
Hu, Xiaobo, et al.. (2021). Intercellular transmission of chronic ER stress: a new mechanism of metabolic diseases. Acta Biochimica et Biophysica Sinica. 53(8). 1109–1111. 1 indexed citations
11.
Hu, Xiaobo, et al.. (2021). Puerarin Inhibits the PERK-eIF2α-ATF4-CHOP Pathway through Inactivating JAK2/STAT3 Signal in Pancreatic beta-Cells. The American Journal of Chinese Medicine. 49(7). 1723–1738. 17 indexed citations
12.
Hu, Xiaobo, et al.. (2021). Intercellular mitochondria transfer: a new perspective for the treatment of metabolic diseases. Acta Biochimica et Biophysica Sinica. 53(7). 958–960. 6 indexed citations
13.
Hu, Xiaobo, et al.. (2020). 1,25-(OH)D protects pancreatic beta cells against HO-induced apoptosis through inhibiting the PERK-ATF4-CHOP pathway. Acta Biochimica et Biophysica Sinica. 53(1). 46–53. 17 indexed citations
14.
15.
Cao, Zhaohui, et al.. (2019). Endoplasmic reticulum stress and destruction of pancreatic β cells in type 1 diabetes. Chinese Medical Journal. 133(1). 68–73. 26 indexed citations
16.
Li, Xiuping, Weidong Yin, Xiaobo Hu, et al.. (2016). Role of Neu-p11/luzindole in the regulation of insulin signaling pathways and insulin resistance. Acta Biochimica et Biophysica Sinica. 48(5). 485–486. 3 indexed citations
17.
Cao, Zhaohui, Quan‐you Zheng, Xiaobo Hu, et al.. (2015). STAT1-Mediated Down-Regulation of Bcl-2 Expression Is Involved in IFN-γ/TNF-α–Induced Apoptosis in NIT-1 Cells. PLoS ONE. 10(3). e0120921–e0120921. 36 indexed citations
18.
Hu, Xiaobo, Chi Zhang, Shenghua Yang, et al.. (2014). Piromelatine, a novel melatonin receptor agonist, stabilizes metabolic profiles and ameliorates insulin resistance in chronic sleep restricted rats. European Journal of Pharmacology. 727. 60–65. 29 indexed citations
19.
Guo, Zhenyu, Moshe Laudon, Zhuowei Hu, et al.. (2009). NEU-P11, a novel melatonin agonist, inhibits weight gain and improves insulin sensitivity in high-fat/high-sucrose-fed rats. Pharmacological Research. 59(4). 248–253. 94 indexed citations
20.
Lin, Guoping, et al.. (2007). Effect of Siraitia Grosvenorii Polysaccharide on Glucose and Lipid of Diabetic RabbitsInduced by Feeding High Fat/High Sucrose Chow. Journal of Diabetes Research. 2007(1). 67435–67435. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuting Wu Breakdown of academic impact, for papers by Mohamed Samir Ahmed Zaki Breakdown of academic impact, for papers by Zhen Shi Breakdown of academic impact, for papers by Deepti Ramachandran Breakdown of academic impact, for papers by Rocco Caminiti Breakdown of academic impact, for papers by Nan Lin Breakdown of academic impact, for papers by Anil Ahsan Breakdown of academic impact, for papers by Mirko Magnone Breakdown of academic impact, for papers by Ching‐Long Lai Breakdown of academic impact, for papers by Sara Santa-Cruz Calvo
Rankless by CCL
2026